Тип публикации: статья из журнала

Год издания: 2014

Идентификатор DOI: 10.3390/v6093663

Ключевые слова: Bundibugyo virus, cDNA clone, Cuevavirus, Ebola, Ebola virus, Ebolavirus, Filovirid, Filoviridae, Filovirus, Genome annotation, ICTV, International Committee on Taxonomy of Viruses, Lloviu virus, Marburg virus, Marburgvirus, Mononegavirad, Mononegavirales, Mononegavirus, Ravn virus, RefSeq, Reston virus, Reverse genetics, Sudan virus, Tai Forest virus, Virus classification, Virus isolate, Virus nomenclature, Virus strain, Virus taxonomy, Virus variant, genetic variability, Letter, molecular genetics, nonhuman, nucleotide sequence, reference database, sequence database, taxonomy, type strain, virus genome, virus typing, classification, genetic selection, genetics, human, molecular evolution, nucleic acid database, Lake Victoria marburgvirus, Databases, Nucleic Acid, Evolution, Molecular, Humans, Selection, Genetic

Аннотация: Sequence determination of complete or coding-complete genomes of viruses is becoming common practice for supporting the work of epidemiologists, ecologists, virologists, and taxonomists. Sequencing duration and costs are rapidly decreasing, sequencing hardware is under modification for use by non-experts, and software is constantlyПоказать полностьюbeing improved to simplify sequence data management and analysis. Thus, analysis of virus disease outbreaks on the molecular level is now feasible, including characterization of the evolution of individual virus populations in single patients over time. The increasing accumulation of sequencing data creates a management problem for the curators of commonly used sequence databases and an entry retrieval problem for end users. Therefore, utilizing the data to their fullest potential will require setting nomenclature and annotation standards for virus isolates and associated genomic sequences. The National Center for Biotechnology Information’s (NCBI’s) RefSeq is a non-redundant, curated database for reference (or type) nucleotide sequence records that supplies source data to numerous other databases. Building on recently proposed templates for filovirus variant naming [<virus name=""> (<strain>)/<isolation host-suffix="">/<country of="" sampling="">/<year of="" sampling="">/<genetic variant="" designation="">-<isolate designation="">], we report consensus decisions from a majority of past and currently active filovirus experts on the eight filovirus type variants and isolates to be represented in RefSeq, their final designations, and their associated sequences. © 2014 by the authors; licensee MDPI, Basel, Switzerland.</isolate></genetic></year></country></isolation></strain></virus>

Журнал: Viruses

Выпуск журнала: Vol. 6, Is. 9

Номера страниц: 3663-3682

• Kuhn J.H. (Integrated Research Facility at Fort Detrick, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Fort Detrick, Frederick, MD, United States)
• Andersen K.G. (FAS Center for Systems Biology, Harvard University, Cambridge, MA, United States)
• B?o Y. (Information Engineering Branch, National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, MD, United States)
• Bavari S. (United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, MD, United States)
• Becker S. (Institut f?r Virologie, Philipps-Universit?t Marburg, Marburg, Germany)
• Bennett R.S. (National Biodefense Analysis and Countermeasures Center, Fort Detrick, Frederick, MD, United States)
• Bergman N.H. (National Biodefense Analysis and Countermeasures Center, Fort Detrick, Frederick, MD, United States)
• Blinkova O. (Information Engineering Branch, National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, MD, United States)
• Bradfute S. (University of New Mexico, Albuquerque, NM, United States)
• Rodney Brister J. (Information Engineering Branch, National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, MD, United States)
• Bukreyev A. (Department of Pathology and Galveston National Laboratory, University of Texas Medical Branch, Galveston, TX, United States)
• Chandran K. (Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY, United States)
• Chepurnov A.A. (Institute of Clinical Immunology, Russian Academy of Science, Siberian Branch, Novosibirsk, Novosibirsk Oblast, United States)
• Davey R.A. (Department of Virology and Immunology, Texas Biomedical Research Institute, San Antonio, TX, United States)
• Dietzgen R.G. (Queensland Alliance for Agriculture and Food Innovation, The University of Queensland, St Lucia, QLD, Australia)
• Doggett N.A. (Los Alamos National Laboratory, Los Alamos, NM, United States)
• Dolnik O. (Institut f?r Virologie, Philipps-Universit?t Marburg, Marburg, Germany)
• Dye J.M. (United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, MD, United States)
• Enterlein S. (Integrated BioTherapeutics, Inc, Gaithersburg, MD, United States)
• Fenimore P.W. (Los Alamos National Laboratory, Los Alamos, NM, United States)
• Formenty P. (World Health Organization, Geneva, Switzerland)
• Freiberg A.N. (Department of Pathology and Galveston National Laboratory, University of Texas Medical Branch, Galveston, TX, United States)
• Garry R.F. (Department of Microbiology and Immunology, Tulane University School of Medicine, New Orleans, AL, United States)
• Garza N.L. (United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, MD, United States)
• Gire S.K. (FAS Center for Systems Biology, Harvard University, Cambridge, MA, United States)
• Gonzalez J.-P. (Metabiota, Inc, San Francisco, CA, United States)
• Griffiths A. (Department of Virology and Immunology, Texas Biomedical Research Institute, San Antonio, TX, United States)
• Happi C.T. (Department of Biological Sciences, College of Natural Sciences, and African Centre of Excellence for Genomics of Infectious Diseases, Redeemer’s University, Lagos-Ibadan, Ogun State, Nigeria)
• Hensley L.E. (Integrated Research Facility at Fort Detrick, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Fort Detrick, Frederick, MD, United States)
• Herbert A.S. (United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, MD, United States)
• Hevey M.C. (National Biodefense Analysis and Countermeasures Center, Fort Detrick, Frederick, MD, United States)
• Hoenen T. (Laboratory for Virology, Division of Intramural Research, National Institute for Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, United States)
• Honko A.N. (Integrated Research Facility at Fort Detrick, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Fort Detrick, Frederick, MD, United States)
• Ignatyev G.M. (Federal State Unitary Company, Microgen Scientific Industrial Company for Immunobiological Medicines, Ministry of Health of the Russian Federation, Moscow, United States)
• Jahrling P.B. (Integrated Research Facility at Fort Detrick, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Fort Detrick, Frederick, MD, United States)
• Johnson J.C. (Integrated Research Facility at Fort Detrick, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Fort Detrick, Frederick, MD, United States)
• Johnson K.M. (Portland, CA, United States)
• Kindrachuk J. (Integrated Research Facility at Fort Detrick, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Fort Detrick, Frederick, MD, United States)
• Klenk H.-D. (Institut f?r Virologie, Philipps-Universit?t Marburg, Marburg, Germany)
• Kochel T.J. (National Biodefense Analysis and Countermeasures Center, Fort Detrick, Frederick, MD, United States)
• Lackemeyer M.G. (Integrated Research Facility at Fort Detrick, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Fort Detrick, Frederick, MD, United States)
• Lackner D.F. (National Biodefense Analysis and Countermeasures Center, Fort Detrick, Frederick, MD, United States)
• Leroy E.M. (Centre International de Recherches M?dicales de Franceville, Franceville, Gabon)
• Lever M.S. (Biomedical Sciences Department, Dstl, Porton Down, Salisbury, Wiltshire, United Kingdom)
• M?hlberger E. (Department of Microbiology and National Emerging Infectious Diseases Laboratory, Boston University School of Medicine, Boston, MA, United States)
• Netesov S.V. (Novosibirsk State University, Novosibirsk, Novosibirsk Region, United States)
• Olinger G.G. (Integrated Research Facility at Fort Detrick, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Fort Detrick, Frederick, MD, United States)
• Omilabu S.A. (Department of Medical Microbiology and Parasitology, College of Medicine of the University of Lagos, Private Mail Bag 12003, Idi-Araba, Lagos, Nigeria)
• Palacios G. (United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, MD, United States)
• Panchal R.G. (United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, MD, United States)
• Park D.J. (The Broad Institute, Cambridge, MA, United States)
• Patterson J.L. (Department of Virology and Immunology, Texas Biomedical Research Institute, San Antonio, TX, United States)
• Paweska J.T. (Center for Emerging and Zoonotic Diseases, National Institute for Communicable Diseases of the National Health Laboratory Service, Sandringham-Johannesburg, Gauteng, South Africa)
• Peters C.J. (Department of Pathology and Galveston National Laboratory, University of Texas Medical Branch, Galveston, TX, United States)
• Pettitt J. (Integrated Research Facility at Fort Detrick, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Fort Detrick, Frederick, MD, United States)
• Pitt L. (United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, MD, United States)
• Radoshitzky S.R. (United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, MD, United States)
• Ryabchikova E.I. (Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences, Novosibirsk, Novosibirsk Region, United States)
• Saphire E.O. (Department of Immunology and Microbial Science and The Skaggs Institute for Chemical Biology, The Scripps Research Institute, La Jolla, CA, United States)
• Sabeti P.C. (FAS Center for Systems Biology, Harvard University, Cambridge, MA, United States)
• Sealfon R. (Computer Science and Artificial Intelligence Laboratory, Massachusetts Institute of Technology, Cambridge, MA, United States)
• Shestopalov A.M. (Novosibirsk State University, Novosibirsk, Novosibirsk Region, United States)
• Smither S.J. (Biomedical Sciences Department, Dstl, Porton Down, Salisbury, Wiltshire, United Kingdom)
• Sullivan N.J. (Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States)
• Swanepoel R. (Zoonoses Research Unit, University of Pretoria, Private bag X20 Hatfield, Pretoria, South Africa)
• Takada A. (Division of Global Epidemiology, Hokkaido University Research Center for Zoonosis Control, Kita-ku, Sapporo, Japan)
• Towner J.S. (Viral Special Pathogens Branch, Division of High-Consequence Pathogens Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States)
• Van Der Groen G. (Prins Leopold Instituut voor Tropische Geneeskunde, Antwerp, Belgium)
• Volchkov V.E. (Laboratory of Molecular basis of viral pathogenicity, CIRI, Inserm U1111, Universit? de Lyon, UCB-Lyon-1, Ecole-Normale-Sup?rieure de Lyon, Lyon cedex 07, France)
• Volchkova V.A. (Laboratory of Molecular basis of viral pathogenicity, CIRI, Inserm U1111, Universit? de Lyon, UCB-Lyon-1, Ecole-Normale-Sup?rieure de Lyon, Lyon cedex 07, France)
• Wahl-Jensen V. (National Biodefense Analysis and Countermeasures Center, Fort Detrick, Frederick, MD, United States)
• Warren T.K. (United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, MD, United States)
• Warfield K.L. (Unither Virology, LLC, Silver Spring, MD, United States)
• Weidmann M. (Institute of Aquaculture, University of Stirling, United Kingdom)
• Nichol S.T. (Viral Special Pathogens Branch, Division of High-Consequence Pathogens Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States)
• Kuhn J.H. (Integrated Research Facility at Fort Detrick, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Fort Detrick, Frederick, MD, United States)

• Scopus